关于儿童牛皮的疾病负担的系统文献评论
Santiago Zuluaga Sanchez1, Tiffanie Tran2, Andrea Garcia3
1Amgen Ltd, Uxbridge, UK.
Dermatology and therapy
|September 12, 2025
概括
儿科牛皮明显影响儿童儿童.
科学领域:
- 皮肤病学和儿科
- 系统文献综述 系统文献综述
- 医疗保健服务研究 医疗服务研究
背景情况:
- 儿科牛皮是一种慢性炎症性皮肤疾病,对生活质量 (QoL) 有重大影响.
- 关于牛皮的现有文献评论在很大程度上忽略了儿科特定数据.
- 这项研究重点关注儿科牛皮的多方面的负担,特别是中度至重度病例.
研究的目的:
- 系统地识别和综合有关儿科牛皮的流行病学,人文和经济负担的证据.
- 专门分析中度至重度儿科牛皮病例中的负担.
主要方法:
- 进行了两次关于儿科牛皮的系统文献审查 (SLR).
- 一个SLR专注于所有严重程度的流行病学和疾病负担.
- 第二个SLR专注于中度至重度病例的人文和经济负担,利用多个数据库和额外的来源.
主要成果:
- 确定了56项研究,揭示了儿童牛皮是一种多系统性疾病,在严重病例中增加了负担.
- 患病率随着年龄的增长而增加;危险因素包括肥胖和喘. 伴随性疾病包括精神,代谢,肌肉骨和胃肠道疾病.
- 疾病的严重程度与代谢综合征,较差的生活质量和增加的护理人员负担相关;经济数据和成本效益分析有限.
结论:
- 关于儿童牛皮的全部负担的证据有限,特别是在中度至重度病例中,包括患病率和经济影响.
- 进一步的研究对于有效的疾病管理和儿童牛皮的资源分配至关重要.
- 新兴疗法看起来很有前途,但它们的全部好处需要进一步的研究.
相关概念视频
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
01:29Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
01:35Pedigree Analysis
88.9K
Overview
88.9K